RetinalGenix Technologies Inc.
RTGN · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | -$1 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $373 | $524 | $809 | $680 |
| G&A Expenses | $1,334 | $899 | $1,067 | $1,496 |
| SG&A Expenses | $1,334 | $1,563 | $1,067 | $1,496 |
| Sales & Mktg Exp. | $0 | $664 | $0 | $0 |
| Other Operating Expenses | $2,610 | $0 | $0 | -$680 |
| Operating Expenses | $4,317 | $2,087 | $1,876 | $1,496 |
| Operating Income | -$4,317 | -$2,087 | -$1,876 | -$2,177 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$4 | -$4 | -$2,038 | -$3 |
| Pre-Tax Income | -$4,321 | -$2,091 | -$3,914 | -$2,179 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4,321 | -$2,091 | -$3,914 | -$2,182 |
| % Margin | – | – | – | – |
| EPS | -0.24 | -0.12 | -0.25 | -0.15 |
| % Growth | -100% | 52% | -66.7% | – |
| EPS Diluted | -0.24 | -0.12 | -0.25 | -0.15 |
| Weighted Avg Shares Out | 17,941 | 17,352 | 15,584 | 14,282 |
| Weighted Avg Shares Out Dil | 17,941 | 17,352 | 15,584 | 14,282 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $4 | $5 | $3 |
| Depreciation & Amortization | $1 | $0 | $0 | $2,177 |
| EBITDA | -$4,316 | -$2,087 | -$3,909 | $0 |
| % Margin | – | – | – | – |